XML 51 R39.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Commitments and Contingencies (Details) | 1 Months Ended | 3 Months Ended | 106 Months Ended
--- | --- | --- | ---
Aug. 31, 2023 USD ($) | Jan. 31, 2020 USD ($) | Mar. 31, 2024 USD ($) | Mar. 31, 2024 USD ($)
Operating lease, penalties and contingent payments payable |  |  | $ 0 |
Oregon Health & Science University Agreement |  |  |  |
Licensing term OHSU agreement |  |  | 8 years |
Days notice required to terminate OHSU agreement |  |  | 45 days |
Days notice required by Fennec to terminate OHSU agreement |  |  | 60 days |
Accrued royalty expenses |  |  | $ 77,000 | $ 314,000
Percentage of royalties |  |  | 1.00% |
Lease Contingencies | Triangle Park, North Carolina |  |  |  |
Monthly lease expense |  |  | $ 400,000 |
Operating lease, number of scheduled payment increases |  |  | 0 | 0
Operating lease, days notice required to terminate agreement |  |  | 30 days |
Lease Contingencies | Hoboken, New Jersey | Office Service Agreement |  |  |  |
Monthly lease expense |  | $ 1,000 |  |
Security deposit |  | $ 2,000 |  |
Lease Contingencies | Dublin, Ireland | Office Service Agreement |  |  |  |
Monthly lease expense |  |  | $ 2,000 |
Security deposit | $ 5,000 |  |  |
Variable rate over prime | 1.50% |  |  |
CIPLA ANDA Litigation |  |  |  |
Days following receipt of Notice Letter to file patent infringement suit |  |  | 45 days |
Duration of FDA's ability to give final approval to proposed products that reference PEDMARK |  |  | 30 months |
PEDMARK's Orphan Drug Exclusivity period |  |  | 7 years |
PEDMARK's exclusivity period under PUMA |  |  | 10 years |
Executive Severance | Rostislav Raykov |  |  |  |
Severance payments due |  |  | $ 608,000 | $ 608,000
Number of severance payments |  |  | 1 | 1
Severance payment term |  |  | P12M |
Executive Severance | Robert Andrade |  |  |  |
Severance payments due |  |  | $ 220,000 | $ 220,000
Number of severance payments |  |  | 1 | 1
Severance payment term |  |  | P6M |
Executive Severance | Adrian Haigh |  |  |  |
Number of severance payments |  |  | 1 | 1
Severance payment term |  |  | P3M |

X
- Definition Days following the receipt of a Notice Letter in which the Company can formally file a patent infringement suit, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | fenc_DaysFollowingReceiptOfNoticeLetterToFilePatentInfringementSuit
Namespace Prefix: | fenc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Days notice required by Fennec to terminate OHSU agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | fenc_DaysNoticeRequiredByFennecToTerminateOhsuAgreement
Namespace Prefix: | fenc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Days notice required to terminate OHSU agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | fenc_DaysNoticeToTerminateOhsuAgreement
Namespace Prefix: | fenc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Duration of FDA's ability to give final approval to proposed products that reference PEDMARK subsequent to the filing of a patent infringement suit, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | fenc_DurationOfFdaSAbilityToGiveFinalApprovalToProposedProductsThatReferencePedmark
Namespace Prefix: | fenc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Licensing term under OHSU agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | fenc_LicensingTermOhsuAgreement
Namespace Prefix: | fenc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents number of severance payments following executive's termination. + References No definition available. + Details
Name: | fenc_NumberOfSeverancePayments
Namespace Prefix: | fenc_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Days notice required to terminate lease agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | fenc_OperatingLeaseDaysNoticeRequiredToTerminateAgreement
Namespace Prefix: | fenc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents number of scheduled payment increases over the duration of the lease agreement. + References No definition available. + Details
Name: | fenc_OperatingLeaseNumberOfScheduledPaymentIncreases
Namespace Prefix: | fenc_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of operating lease penalties and contingent payments due. + References No definition available. + Details
Name: | fenc_OperatingLeasePenaltiesAndContingentPaymentsPayable
Namespace Prefix: | fenc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Duration of PEDMARK's exclusivity period under the European Market Exclusivity for Pediatric Use (PUMA) program, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | fenc_PedmarkSExclusivityPeriodUnderPuma
Namespace Prefix: | fenc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Duration of PEDMARK's exclusivity period due to Orphan Drug Exclusivity status, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | fenc_PedmarkSOrphanDrugExclusivityPeriod
Namespace Prefix: | fenc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the percentage of royalties to be received as consideration. + References No definition available. + Details
Name: | fenc_RoyaltiesPercentage
Namespace Prefix: | fenc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The variable rate of interest (added to the current prime interest rate) used in determining the Company's incremental borrowing rate. + References No definition available. + Details
Name: | fenc_VariableInterestRateOverPrime
Namespace Prefix: | fenc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of operating lease expense. Excludes sublease income. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 4 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4 + Details
Name: | us-gaap_OperatingLeaseExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Describes the maximum potential amount of consideration, undiscounted, that could be transferred under the registration payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482804/825-20-50-1 + Details
Name: | us-gaap_RegistrationPaymentArrangementMaximumPotentialConsideration
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Describes the term of the registration payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482804/825-20-50-1 + Details
Name: | us-gaap_RegistrationPaymentArrangementTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_RoyaltyExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition This element represents money paid in advance to protect the provider of a product or service, such as a lessor, against damage or nonpayment by the buyer or tenant (lessee) during the term of the agreement. Such damages may include physical damage to the property, theft of property, and other contractual breaches. Security deposits held may be interest or noninterest bearing. + References No definition available. + Details
Name: | us-gaap_SecurityDepositLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=fenc_OregonHealthAndScienceUniversityAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=fenc_LeaseContingenciesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=fenc_TriangleParkNorthCarolinaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=fenc_HobokenNewJerseyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=fenc_OfficeServiceAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_IE
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=fenc_LitigationCiplaAndaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=fenc_ExecutiveSeveranceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=fenc_RobertAndradeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=fenc_AdrianHaighMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |